Jacobs Levy Equity Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-595,016	Closed	-$1.32M	–	980
2024 Q2	$1.32M	Sell	595,016 -109,081	-15%	-$257K	0.01%	676
2024 Q1	$1.89M	Sell	704,097 -353,787	-33%	-$860K	0.01%	606
2023 Q4	$3.16M	Sell	1,057,884 -1,206,475	-53%	-$1.56M	0.02%	514
2023 Q3	$2.22M	Buy	2,264,359 +1,836,567	+429%	+$2.66M	0.01%	544
2023 Q2	$595K	Buy	427,792 +272,289	+175%	+$380K	﹤0.01%	789
2023 Q1	$247K	Buy	155,503 +9,484	+6%	+$49K	﹤0.01%	885
2022 Q4	$910K	Buy	+146,019	New	+$1.04M	0.01%	691
2021 Q1	–	Sell	-35,072	Closed	-$912K	–	1048
2020 Q4	$912K	Buy	35,072 +120	+0.3%	+$3.6K	0.01%	746
2020 Q3	$1.3M	Sell	34,952 -3,668	-9%	-$145K	0.01%	606
2020 Q2	$1.98M	Buy	38,620 +461	+1%	+$19.3K	0.02%	534
2020 Q1	$1.2M	Sell	38,159 -3,088	-7%	-$163K	0.02%	583
2019 Q4	$2.46M	Buy	41,247 +8,937	+28%	+$402K	0.02%	510
2019 Q3	$1.18M	Buy	32,310 +1,260	+4%	+$49.9K	0.01%	592
2019 Q2	$1.44M	Sell	31,050 -670	-2%	-$31.5K	0.02%	577
2019 Q1	$1.27M	Buy	31,720 +23,570	+289%	+$1.06M	0.02%	613
2018 Q4	$375K	Buy	8,150 +300	+4%	+$14.5K	0.01%	778
2018 Q3	$348K	Buy	+7,850	New	+$360K	﹤0.01%	847
2016 Q2	–	Sell	-18,500	Closed	-$313K	–	1172
2016 Q1	$313K	Buy	+18,500	New	+$298K	0.01%	860

Other funds holding ESPR